
Calculus Capital
Description
Calculus Capital is a prominent UK-based private equity fund manager, specializing in creating and managing tax-efficient investment vehicles, primarily Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) funds, for individual investors. Established in 1999, the firm has built a strong reputation for backing established, unquoted UK companies with significant growth potential. Their investment approach is geared towards providing growth capital, supporting management buyouts, and facilitating buy-ins across a diverse range of sectors.
The firm's investment strategy focuses on identifying businesses with proven models, strong management teams, and clear pathways to expansion. Calculus Capital is sector-agnostic, having invested across various industries including healthcare, technology, media, business services, consumer goods, and industrials. They aim to partner with companies that can benefit from their strategic guidance and financial expertise, helping them scale operations, develop new products, or enter new markets.
Calculus Capital typically deploys initial investments ranging from £2 million to £5 million, equivalent to approximately $2.54 million to $6.35 million USD, with provisions for follow-on funding to support continued growth. Since its inception, the firm has demonstrated a robust track record, having invested over £250 million (approximately $317.5 million USD) into more than 90 companies. This extensive experience and consistent performance have earned them multiple accolades, including being recognized as "Best EIS Fund Manager" at the Growth Investor Awards on several occasions, underscoring their standing as a leading player in the UK's private equity landscape.
Investor Profile
Calculus Capital has backed more than 67 startups, with 5 new investments in the last 12 months alone. The firm has led 46 rounds, about 69% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Ireland.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Led 3 rounds in the past year.
- Typical check size: $2.5M – $6.3M.
Stage Focus
- Series Unknown (54%)
- Series A (15%)
- Seed (12%)
- Series B (6%)
- Post Ipo Equity (6%)
- Private Equity (4%)
- Undisclosed (3%)
Country Focus
- United Kingdom (88%)
- United States (9%)
- Ireland (1%)
- South Africa (1%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Medical
- Artificial Intelligence (Ai)
- Innovation Management
- Life Science
- Therapeutics
- Biopharma
- Machine Learning
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.